JP2005523329A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005523329A5 JP2005523329A5 JP2003587152A JP2003587152A JP2005523329A5 JP 2005523329 A5 JP2005523329 A5 JP 2005523329A5 JP 2003587152 A JP2003587152 A JP 2003587152A JP 2003587152 A JP2003587152 A JP 2003587152A JP 2005523329 A5 JP2005523329 A5 JP 2005523329A5
- Authority
- JP
- Japan
- Prior art keywords
- glycyl
- preparation according
- aqueous preparation
- alkali metal
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002112864 | 2002-04-16 | ||
| PCT/JP2003/004745 WO2003086471A2 (en) | 2002-04-16 | 2003-04-15 | Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005523329A JP2005523329A (ja) | 2005-08-04 |
| JP2005523329A5 true JP2005523329A5 (enExample) | 2006-04-13 |
| JP3927954B2 JP3927954B2 (ja) | 2007-06-13 |
Family
ID=29243336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003587152A Expired - Fee Related JP3927954B2 (ja) | 2002-04-16 | 2003-04-15 | カンプトテシン誘導体含有水性製剤およびそれを凍結乾燥した医薬組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20050215485A1 (enExample) |
| EP (1) | EP1501549A2 (enExample) |
| JP (1) | JP3927954B2 (enExample) |
| KR (1) | KR100700963B1 (enExample) |
| CN (1) | CN100544769C (enExample) |
| AR (1) | AR039272A1 (enExample) |
| AU (1) | AU2003223120B2 (enExample) |
| BR (1) | BR0309283A (enExample) |
| CA (1) | CA2480425A1 (enExample) |
| HR (1) | HRP20040894A2 (enExample) |
| ME (1) | MEP31308A (enExample) |
| MX (1) | MXPA04010178A (enExample) |
| MY (1) | MY136696A (enExample) |
| NO (1) | NO20044964L (enExample) |
| PL (1) | PL371677A1 (enExample) |
| RS (1) | RS91204A (enExample) |
| RU (1) | RU2315623C2 (enExample) |
| TW (1) | TW200306314A (enExample) |
| UA (1) | UA77295C2 (enExample) |
| WO (1) | WO2003086471A2 (enExample) |
| ZA (1) | ZA200408008B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080242691A1 (en) * | 2004-02-13 | 2008-10-02 | Kabushiki Kaisha Yakult Honsha | Aqueous Solution Preparation Containing Camptothecins |
| AU2005244768B2 (en) | 2004-04-27 | 2011-06-09 | Wellstat Biologics Corporation | Cancer treatment using viruses and camptothecins |
| AU2006270297B2 (en) | 2005-07-14 | 2013-01-17 | Wellstat Biologics Corporation | Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| JP2007260275A (ja) * | 2006-03-29 | 2007-10-11 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びイオントフォレーシス投与用組成物 |
| TWI505834B (zh) | 2009-06-22 | 2015-11-01 | Wyeth Llc | 組合物及製備金黃色葡萄球菌血清型５及８莢膜多醣結合物之免疫原性組合物之方法 |
| BRPI1015567A2 (pt) | 2009-06-22 | 2021-08-31 | Wyeth Llc | Composições imunogênicas de antígenos de staphylococcus aureus |
| CN102764260B (zh) * | 2011-04-30 | 2014-07-30 | 正大天晴药业集团股份有限公司 | 一种喜树碱衍生物的药物组合物及其制备方法 |
| WO2013011598A1 (ja) * | 2011-07-15 | 2013-01-24 | コニカミノルタホールディングス株式会社 | 溶解助剤を利用したリポソーム含有製剤およびその製造方法 |
| CN113304278A (zh) | 2014-12-26 | 2021-08-27 | 日本化药株式会社 | 喜树碱类高分子衍生物的药物制剂 |
| KR20180039628A (ko) * | 2015-09-03 | 2018-04-18 | 니폰 가야꾸 가부시끼가이샤 | 캄프토테신류 고분자 유도체를 함유하는 의약 조성물 |
| WO2017053920A1 (en) | 2015-09-25 | 2017-03-30 | Zy Therapeutics Inc. | Drug formulation based on particulates comprising polysaccharide-vitamin conjugate |
| EP3424513A4 (en) * | 2016-03-01 | 2019-10-23 | Nippon Kayaku Kabushiki Kaisha | PHARMACEUTICAL PREPARATION WITH CAMPTOTHECINOUS POLYMER DERIVATIVE |
| CN109481691A (zh) * | 2018-11-20 | 2019-03-19 | 珠海天香苑生物科技发展股份有限公司 | 吉西他滨-羧甲基多糖共轭物、制备方法及其用途 |
| EP4438062A1 (en) * | 2021-11-26 | 2024-10-02 | Astellas Pharma Inc. | Indocyanine compound-containing solid pharmaceutical composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340817A (en) * | 1987-04-14 | 1994-08-23 | Research Triangle Institute | Method of treating tumors with anti-tumor effective camptothecin compounds |
| ATE136898T1 (de) * | 1991-10-29 | 1996-05-15 | Glaxo Wellcome Inc | Wasserlösliche camptothecinderivate |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| IT1282673B1 (it) * | 1996-02-23 | 1998-03-31 | Ist Naz Stud Cura Dei Tumori | Derivati della camptotecina e loro uso come agenti antitumorali |
| TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| US6288072B1 (en) * | 1999-12-29 | 2001-09-11 | Monroe E. Wall | Camptothecin β-alanine esters with topoisomerase I inhibition |
| AR030207A1 (es) * | 2000-04-07 | 2003-08-13 | Daiichi Seiyaku Co | Composicion farmaceutica que contiene un derivado de camptotecina y procedimiento de preparacion de la misma |
| BR0112417A (pt) * | 2000-07-13 | 2003-07-01 | Daiichi Seiyaku Co | Composições farmacêuticas contendo composto dds |
| TWI313609B (en) * | 2001-08-21 | 2009-08-21 | Mitsubishi Tanabe Pharma Corp | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor |
-
2003
- 2003-04-01 TW TW092107354A patent/TW200306314A/zh unknown
- 2003-04-09 AR ARP030101238A patent/AR039272A1/es unknown
- 2003-04-11 MY MYPI20031367A patent/MY136696A/en unknown
- 2003-04-15 PL PL03371677A patent/PL371677A1/xx not_active Application Discontinuation
- 2003-04-15 AU AU2003223120A patent/AU2003223120B2/en not_active Ceased
- 2003-04-15 CA CA002480425A patent/CA2480425A1/en not_active Abandoned
- 2003-04-15 BR BR0309283-6A patent/BR0309283A/pt not_active IP Right Cessation
- 2003-04-15 EP EP03719110A patent/EP1501549A2/en not_active Withdrawn
- 2003-04-15 ME MEP-313/08A patent/MEP31308A/xx unknown
- 2003-04-15 HR HR20040894A patent/HRP20040894A2/xx not_active Application Discontinuation
- 2003-04-15 CN CNB038082292A patent/CN100544769C/zh not_active Expired - Fee Related
- 2003-04-15 KR KR1020047016514A patent/KR100700963B1/ko not_active Expired - Fee Related
- 2003-04-15 UA UA20041109367A patent/UA77295C2/uk unknown
- 2003-04-15 MX MXPA04010178A patent/MXPA04010178A/es active IP Right Grant
- 2003-04-15 WO PCT/JP2003/004745 patent/WO2003086471A2/en not_active Ceased
- 2003-04-15 RS YU91204A patent/RS91204A/sr unknown
- 2003-04-15 RU RU2004133349/15A patent/RU2315623C2/ru not_active IP Right Cessation
- 2003-04-15 US US10/509,912 patent/US20050215485A1/en not_active Abandoned
- 2003-04-15 JP JP2003587152A patent/JP3927954B2/ja not_active Expired - Fee Related
-
2004
- 2004-10-05 ZA ZA200408008A patent/ZA200408008B/en unknown
- 2004-11-15 NO NO20044964A patent/NO20044964L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5936546B2 (ja) | ６−フルオロ−３−ヒドロキシ−２−ピラジンカルボキサミドのメグルミン塩 | |
| JP2005523329A5 (enExample) | ||
| US12053502B2 (en) | Daptomycin formulations | |
| ES2648367T3 (es) | Procedimiento de preparación de una composición farmacéutica liofilizada que contiene mitomicina C | |
| JPWO2012043700A1 (ja) | ６−フルオロ−３−ヒドロキシ−２−ピラジンカルボキサミドのナトリウム塩 | |
| CA2341568A1 (en) | Stabilized pharmaceutical composition in lyophilized form | |
| PT1988913E (pt) | Formulação líquida de g-csf | |
| JPH1129497A5 (enExample) | ||
| KR100546450B1 (ko) | 약학 조성물 | |
| JP7043156B2 (ja) | ベンゾアゼピン化合物含有凍結乾燥組成物 | |
| WO2002102383A1 (fr) | Preparation de cilostazol aqueuse pour injections | |
| JP3927954B2 (ja) | カンプトテシン誘導体含有水性製剤およびそれを凍結乾燥した医薬組成物 | |
| JP4142149B2 (ja) | バンコマイシンの凍結乾燥製剤 | |
| JPWO1999036065A1 (ja) | 医薬組成物 | |
| TWI242447B (en) | An injectable pharmaceutical compositions of dalfopristine/quinupristine combination | |
| WO2017085696A1 (en) | Parenteral formulations of melphalan | |
| JP2002201137A (ja) | ビダラビン注射用乾燥製剤 | |
| EA045403B1 (ru) | Лиофилизированная композиция, содержащая соединение бензоазепина | |
| JPH01156925A (ja) | ネオカルチノスタチン誘導体の凍結乾操製剤組成物 | |
| HK40063745B (zh) | 含有苯并氮杂卓化合物的冻干组合物 | |
| JPH0710753A (ja) | 注射剤 | |
| JP2018095593A (ja) | 凍結乾燥製剤及びその製造方法 | |
| HK1183014B (en) | Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide | |
| JPWO1998043643A1 (ja) | アシクロビル水溶液製剤 |